Clinical Trial Update: Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes ongoing Phase 1/2 studies evaluating super-selective intra-arterial repeated infusion of cetuximab for newly diagnosed gliobla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain Neoplasm
• Brain Tumor
• Glioblastoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Northwell Health | Conditions: Glioblastoma, Brain Cancer | Phase 1, Phase 2 | Status: RECRUITING